Screener
Gilead Sciences GILD EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Gilead Sciences’s reported figures.
The source filing: Gilead Sciences’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000882095-26-000024
FAQ
- What is Gilead Sciences's EBITDA?
- Gilead Sciences (GILD) reported EBITDA of $2.68B in Q1 2026.
- How has Gilead Sciences's EBITDA changed year-over-year?
- Gilead Sciences's EBITDA increased by 14.8% year-over-year, from $2.33B to $2.68B.
- What is the long-term trend for Gilead Sciences's EBITDA?
- Over 4 years (2021 to 2025), Gilead Sciences's EBITDA has grown at a 0.4% compound annual growth rate (CAGR), from $10.25B to $10.39B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Gilead Sciences's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude